CIK 0001867096 · Large accelerated filer
Xeris Biopharma Holdings, Inc.
Sign in to watch- Ticker
- XERS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 871082097
- Phone
- 844-445-5704
- Business address
- 1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
- 4 Planned sale See Remarks sold 15,000 shares at $8.49 ($127,308)
- 4 Planned sale See Remarks sold 16,666 shares at $8.49 ($141,434)
- 4 Planned sale See Remarks sold 5,000 shares at $8.50 ($42,500)
- 4 Shares withheld for taxes See Remarks gave up 36,645 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 21,918 shares (to pay taxes)
- 4 Planned sale See Remarks sold 5,000 shares at $8.50 ($42,500)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale See Remarks sold 15,000 shares at $8.02 ($120,240)
- 4 Planned sale See Remarks sold 16,666 shares at $8.01 ($133,553)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Unregistered share sale · Other events
- 4 Planned sale See Remarks sold 45,000 shares at an average $8.52 ($383,176)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Grant or award Director acquired 33,582 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale See Remarks sold 90,000 shares at $8.03 ($722,511)
- 4 Planned sale See Remarks sold 16,666 shares at $8.03 ($133,860)
Page 2 of 18 · 346 filings